GRACE

cancergrace.org

 

GRACE
Avatar

Treatment Options for Patients With Head & Neck Cancer and High PD-L1

By GRACE FEATURING Jared Weiss
June 29, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

15:18
Treatment Considerations in CLL: Challenging Patient Cases

Treatment Considerations for Ibrutinib-Intolerant Patients - A Patie…

Feat. M. Shadman

Featured Video

18:47
Treatment Considerations in CLL: Challenging Patient Cases

Treatment Considerations in R/R CLL - A Patient Case Study

Feat. J. N. Allan
Head and Neck
04:46
GRACE

Emerging Treatment Options for Head and Neck Cancer

Feat. J. Weiss
04:33
GRACE

Treatment Options for Patients With Head & Neck Cancer and High …

Feat. J. Weiss
03:48
GRACE

Treatment of Recurrent/Metastatic HPV+ SCCHN

Feat. J. Weiss
03:29
GRACE

ASCO 2022 Updates on Immunotherapy Treatments in Patients With Head …

Feat. K. Gold, S. Sheth
03:31
GRACE

ASCO 2022 Updates on Nonsurgical Treatment in Head and Neck Cancer: …

Feat. K. Gold, S. Sheth
04:08
GRACE

ASCO 2022 Updates on Deintensification for Nasopharyngeal Cancer

Feat. K. Gold, S. Sheth
11:04
GRACE

2021 ASCO ESMO Head & Neck Recap: HPV and Head & Neck Cancer

Feat. J. Weiss, S. Sheth
09:34
GRACE

2021 ASCO ESMO Head & Neck Recap: Recent Data, Developments in P…

Feat. J. Weiss, S. Sheth
11:06
GRACE

ASCO/ESMO Update on Locally Advanced HNSCC: Does the anti-PD1 Pembro…

Feat. J. Bauml, J. Weiss, K. Gold, R. Mehra
09:02
GRACE

ASCO/ESMO Update on IO in Locally Advanced HNSCC: Does the Addition …

Feat. J. Bauml, J. Weiss, K. Gold, R. Mehra
05:20
GRACE

ASCO 2018 Head and Neck Roundtable Mucositis

Feat. J. Bauml, J. Weiss
12:15
GRACE

ASCO 2018 Head and Neck Roundtable Attempts to Decrease Toxicity of …

Feat. J. Bauml, J. Weiss
09:16
GRACE

ASCO 2018 Advances in Immunotherapy in Head and Neck Cancer

Feat. J. Bauml, J. Weiss